Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Mortality Risk in Patients Receiving Drug Regimens with Theophylline for Chronic Obstructive Pulmonary Disease
Pharmacotherapy, 08/26/09
Lee TA et al. – Patients receiving regimens that included theophylline had slightly increased risks of mortality, COPD exacerbations, and COPD hospitalizations compared with patients receiving the same regimens without theophylline. However, the benefits of theophylline on other factors, including symptoms, quality of life, and activities of daily living, were not measured. Clinicians should consider all of the potential benefits and harms associated with theophylline when making treatment recommendations.
Related Articles
Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma
Osteoporosis International, 10/13/09
Relevance Score: 92%
Interaction in COPD experiment (ICE): A hazardous combination of cigarette smoking and bronchodilation in chronic obstructive pulmonary disease
Medical Hypotheses, 10/08/09
Relevance Score: 91%
Molecular Characterization of Chronic Obstructive Pulmonary Disease-Related Non-Small Cell Lung Cancer Through Aberrant Methylation and Alterations of EGFR Signaling
Annals of Surgical Oncology, 10/23/09
Relevance Score: 90%
Tiotropium HandiHaler in the treatment of COPD: A safety review
International Journal of COPD, 10/29/09
Relevance Score: 89%
Living with advanced chronic obstructive pulmonary disease: patients concerns regarding death and dying
Palliative Medicine, 10/16/09
Relevance Score: 89%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of Lovastatin on Primary Prevention of Cardiovascular Events in Mild CKD and Kidney Function Loss: A Post Hoc Analysis of the Air Force/Texas Coronary Atherosclerosis Prevention Study - Corrected Proof
American Journal of Kidney Diseases, 11/30/09
Phase 1 Trial of Adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) Study Group
American Journal of Kidney Diseases, 11/30/09
Nephroprotective Effect of Withania somnifera: A Dose-Dependent Study
Renal Failure, 11/30/09
Today in General Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Carotid Intima-Media Thickness: Knowledge and Application to Everyday Practice
Postgraduate Medicine, 11/25/09
Chronic Obstructive Pulmonary Disease: Role of Bacteria and Updated Guide to Antibacterial Selection in the Older Patient
Drugs & Aging, 11/25/09
Insulin Resistance in Adolescents with Type 1 Diabetes and Its Relationship to Cardiovascular Function
Journal of Clinical Endocrinology and Metabolism, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


